Can inflammation raise ferritin and disrupt thyroid regulation?

Systemic inflammation exerts a profound, multi-layered regulatory influence on both iron homeostasis and thyroid physiology, bridging immune activation with metabolic adaptation.

Ferritin as an inflammatory marker

• Cytokine-driven synthesis: Pro-inflammatory cytokines, particularly interleukin-6 (IL-6), IL-1β, and tumor necrosis factor-alpha (TNF-α), act as positive acute-phase reactants that elevate serum ferritin independently of cellular iron stores.
• Molecular pathway: IL-6 activates the JAK/STAT3 signaling cascade, directly upregulating the transcription of ferritin heavy chain (FTH1) genes in hepatocytes and macrophages.

Mechanistic impairment of thyroid pathways

• Deiodinase disruption: Cytokines downregulate the activating deiodinases (D1 and D2) while upregulating the inactivating enzyme (D3). TNF-α and IL-1β suppress hepatic DIO1 promoter activity through NF-κB activation. Post-translationally, inflammatory oxidative stress depletes intracellular thiol cofactors, directly disabling D1 and D2 catalytic activity.
• Thyroid receptor resistance: IL-1β and TNF-α downregulate TRα and TRβ1 gene expression. Furthermore, activated NF-κB and AP-1 physically interfere with thyroid receptors (TRs) and compete for crucial, limiting coactivators like SRC-1 and CBP, resulting in cellular resistance to thyroid hormones.
• HPT axis deregulation: Systemic cytokines centrally reset the hypothalamic-pituitary-thyroid (HPT) axis. Inflammation upregulates D2 in hypothalamic tanycytes, increasing local T3 generation. This local hyperthyroidism suppresses TRH synthesis in the paraventricular nucleus despite low peripheral thyroid hormone levels, while cytokines simultaneously blunt pituitary TSH secretion. This is compounded by a bidirectional loop where compromised TR signaling fails to antagonize inflammatory pathways like STAT3 recruitment.

Bottom line

• Elevated ferritin serves as a reliable marker of systemic inflammation, which concurrently disrupts thyroid economy by suppressing peripheral T4-to-T3 conversion, inducing cellular thyroid receptor resistance, and centrally resetting the HPT axis to suppress TRH and TSH.